bioRxiv Science⌕ Search

bioRxiv · 10.1101/2022.08.09.503347

Stratification of responses to tDCS intervention in a healthy paediatric population based on resting-state EEG profiles

Abstract

Transcranial Direct Current Stimulation (tDCS) is a non-invasive neuromodulation technique with a wide variety of applications in both the clinical and cognitive psychology domains. As increasingly acknowledged, its effectiveness is subject dependent, which may lead to timely and costly treatments with ineffective results if this variability is not taken into account. We propose the usage of electroencephalography (EEG) for the analysis and prediction of individual responses to tDCS. In this context the application of machine learning can be of enormous help. We analysed resting-state EEG activity to identify subgroups of participants with an homogeneous electrophysiological profile and their response to different tDCS interventions. The study described herein, which focuses on healthy controls, was conducted within a clinical trial for the development of treatments based on tDCS for age-matched children diagnosed with Attention Deficit Hyperactivity Disorder (ADHD) and Autism Spectrum Disorder (ASD). We have studied a randomized, double-blind, sham-controlled tDCS intervention in 56 healthy children and adolescents aged 10-17, applied in 2 parallel groups over 2 target regions, namely left Dorsolateral Prefrontal Cortex (lDLPFC) and right Inferior Frontal Gyrus (rIFG). Cognitive behavioural tasks were used to both activate particular brain areas during the stimulation and to assess the impact of the intervention afterwards. We have implemented an unsupervised learning approach to stratify participants based on their resting-state EEG spectral features before the tDCS application. We have then applied a correlational analysis to identify EEG profiles associated with tDCS subject response to the specific stimulation sites and the presence or not of concurrent tasks during the intervention. In the results we found specific digital electrophysiological profiles that can be associated to a positive response, whereas subjects with other profiles respond negatively or do not respond to the intervention. Findings suggest that unsupervised machine learning procedures, when associated with proper visualization features, can be successfully used to interpret and eventually to predict responses of individuals to tDCS treatment.

Source connections

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Dagnino, P. C., Braboszcz, C., Kroupi, E., Splittgerber, M., Brauer, H., Dempfle, A., Breitling-Ziegler, C., Prehn-Kristensen, A., Krauel, K., Siniatchkin, M., Moliadze, V., Soria-Frisch, A.. 2022-08-11. Stratification of responses to tDCS intervention in a healthy paediatric population based on resting-state EEG profiles. https://doi.org/10.1101/2022.08.09.503347

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

The Unreasonable Effectiveness of Cell Types in Describing Neuronal Physiological Features

Single-cell RNA sequencing (scRNA-seq) captures detailed gene expression profiles at scale, while patch-clamp recordings measure intrinsic neuronal electrophysiological properties. Modeling the relations between these two modalities remains a challenge. Here, we compare how well electrophysiological features can be predicted by traditional transcriptomic cell type classification, representations derived from a foundational model (scGPT) pretrained on large-scale scRNA-seq datasets, ion channel-coding genes, and highly variable genes. Using paired transcriptomic and electrophysiological patch-sequencing data from 495 human neurons from neurosurgical tissue, we find that cluster-level cell type representations consistently outperform highly variable gene selection, ion channel gene selection, and context-enriched scGPT embeddings. Notably, performance varies across model architectures and initializations, and the best results are obtained by combining the outputs of separate cell type and scGPT-based models. Together, these findings suggest that traditional discrete cellular classification is highly effective in predicting physiological features. For maximum performance it can be complemented by pretrained transformer models.

neuroscience↗

A nonlinear inhibition pathway underlying cortical responses to tuned holographic optogenetic perturbations

Optogenetics enables causal manipulation of cortical activity. Perturbation responses can be counterintuitive due to network interactions, making theory essential for predicting them. Existing approaches often rely on linear approximations, which fail for many biologically relevant perturbations. Here we develop a nonlinear theory of responses to holographic perturbations in cell-type-specific recurrent networks with structured connectivity. We fit a nonlinear model to mouse V1 data, which shows cotuned-ensemble suppression: perturbing spatially clustered neurons with similar preferred orientations yields markedly stronger short-range suppression than perturbing untuned ensembles. We show that cotuned-ensemble suppression arises from a feature-tuned, nonlinear inhibition pathway implicating somatostatin-positive (SST) interneurons. The theory predicts that cotuned ensembles suppress parvalbumin-positive (PV) neurons but facilitate SST neurons, and links the degree of cotuned-ensemble suppression or facilitation to the variance of the SST response. This framework identifies mechanisms by which nonlinear inhibition sculpts cortical dynamics and establishes a predictive basis for targeted optogenetic interventions.

neuroscience↗

Proteomic signatures of APOE ε4 across human tissues and cell types in Alzheimers disease

The apolipoprotein E {varepsilon}4 (APOE {varepsilon}4) allele is the strongest genetic risk factor for late-onset Alzheimers disease (AD). However, the underlying molecular mechanisms remain unclear. This study included 1691 participants from the Religious Orders Study and Rush Memory and Aging Project (ROSMAP), 1226 participants from the Accelerating Medicines Partnership - Alzheimers Disease (AMP-AD) Diverse Cohorts Study, and 735 participants from the Alzheimers Disease Neuroimaging Initiative (ADNI). To characterise APOE {varepsilon}4 molecular effects, we analysed proteomic data from plasma, cerebrospinal fluid (CSF), and induced pluripotent stem cell (iPSC)-derived astrocytes and neurons, as well as transcriptomic and proteomic data from multiple brain regions. The association of APOE {varepsilon}4 with AD neuropathology was also examined. APOE {varepsilon}4 carriers shared a plasma proteomic signature enriched for immune processes, irrespective of AD diagnosis. A machine learning classifier trained on this signature discriminated APOE {varepsilon}4 carriers from non-carriers in an independent cohort using CSF proteomics. APOE {varepsilon}4 carriage was associated with higher Braak stages and Consortium to Establish a Registry for Alzheimers Disease (CERAD) score. However, only limited APOE {varepsilon}4-associated transcriptomic and proteomic changes were observed in bulk brain tissue, with poor cross-layer concordance. Proteomic analyses of iPSC-derived astrocytes and neurons further revealed cell-type-specific APOE {varepsilon}4-associated changes. APOE {varepsilon}4 is associated with a consistent proteomic signature across plasma and CSF. Its molecular effects in the brain differ across cell types, brain regions and molecular layers. These findings support the need for cell-type-resolved multi-omic studies to elucidate how APOE {varepsilon}4 confers AD risk.

neuroscience↗